tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Harmony Biosciences Holdings Inc

HRMY
Add to Watchlist
35.760USD
-0.250-0.69%
Close 07-28 16:00（ET）Quotes delayed by 15 min
2.07BMarket Cap
14.15P/E TTM

Harmony Biosciences Holdings Inc

35.760
-0.250-0.69%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

HRMY Financials

See Harmony Biosciences Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Harmony Biosciences Holdings Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/1.00
Revenue / Forecast
--/248.41M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
868.45M
21.51%
EPS(YoY)
2.76
7.92%
Analyst Rating
BUY
2026/07/28
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-29.32%0.56
-54.48%0.39
9.05%0.88
239.17%0.69
17.73%0.79
89.89%0.87
26.15%0.81
-64.32%0.20
36.79%0.68
-44.10%0.46
--0.64
--0.57
--0.49
--0.82
----
----
----
----
----
----
Revenue
16.59%215.39M
21.12%243.78M
28.71%239.46M
16.01%200.49M
19.48%184.73M
19.51%201.27M
16.08%186.04M
28.76%172.81M
29.79%154.62M
31.26%168.41M
36.74%160.27M
25.40%134.22M
39.63%119.13M
40.67%128.31M
45.18%117.21M
44.98%107.03M
42.97%85.31M
62.05%91.21M
77.01%80.73M
94.24%73.82M
Net Profit
-28.69%32.49M
-54.55%22.49M
10.35%50.87M
243.16%39.78M
18.85%45.56M
85.95%49.48M
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-45.15%26.61M
-56.27%38.46M
45.77%34.30M
37.24%29.48M
113.56%48.51M
1014.17%87.94M
66.69%23.53M
190.89%21.48M
11020.19%22.71M
-134.41%-9.62M
234.79%14.12M
Net Margin
-38.84%15.08%
-62.48%9.22%
-14.26%21.24%
195.79%19.84%
-0.53%24.66%
55.59%24.58%
3.24%24.78%
-73.75%6.71%
0.17%24.79%
-58.21%15.80%
--24.00%
--25.56%
--24.75%
--37.81%
----
----
----
----
----
----
Gross Margin
-4.05%79.33%
-1.49%71.88%
-2.49%75.09%
-0.53%80.97%
0.56%82.68%
-1.90%72.97%
-3.56%77.01%
0.04%81.40%
-0.40%82.22%
-5.91%74.38%
--79.85%
--81.37%
--82.56%
--79.05%
----
----
----
----
----
----
Debt to assets ratio
-24.97%12.49%
-28.26%12.87%
-29.21%13.95%
-28.48%15.53%
-25.80%16.64%
-24.79%17.94%
-22.27%19.70%
-13.78%21.72%
-16.26%22.43%
-16.12%23.85%
--25.35%
--25.19%
--26.79%
--28.44%
----
----
----
----
----
----
Income Statement
Revenue
16.59%215.39M
21.12%243.78M
28.71%239.46M
16.01%200.49M
19.48%184.73M
19.51%201.27M
16.08%186.04M
28.76%172.81M
29.79%154.62M
31.26%168.41M
36.74%160.27M
25.40%134.22M
39.63%119.13M
40.67%128.31M
45.18%117.21M
44.98%107.03M
42.97%85.31M
62.05%91.21M
77.01%80.73M
94.24%73.82M
Operating profit
23.19%69.29M
-30.81%38.56M
6.12%65.49M
25.30%48.18M
8.09%56.24M
38.64%55.73M
-4.34%61.71M
-18.02%38.45M
28.72%52.03M
-15.58%40.20M
442.05%64.51M
41.63%46.90M
46.69%40.42M
66.30%47.61M
-43.47%11.90M
42.06%33.12M
89.61%27.56M
269.05%28.63M
102.82%21.05M
175.72%23.31M
Net Profit
-28.69%32.49M
-54.55%22.49M
10.35%50.87M
243.16%39.78M
18.85%45.56M
85.95%49.48M
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-45.15%26.61M
-56.27%38.46M
45.77%34.30M
37.24%29.48M
113.56%48.51M
1014.17%87.94M
66.69%23.53M
190.89%21.48M
11020.19%22.71M
-134.41%-9.62M
234.79%14.12M
Balance Sheet
Current assets
21.18%778.82M
56.58%907.01M
60.57%838.80M
50.84%691.35M
34.03%642.69M
28.42%579.25M
12.83%522.40M
0.59%458.34M
14.69%479.50M
12.69%451.07M
21.18%463.00M
41.20%455.64M
49.18%418.09M
40.73%400.29M
58.74%382.08M
57.64%322.70M
57.67%280.26M
8.20%284.44M
-3.82%240.69M
108.28%204.71M
Total current liabilities
24.11%217.34M
44.01%252.13M
38.52%223.40M
22.89%180.13M
13.53%175.12M
6.90%175.08M
43.48%161.28M
57.54%146.58M
80.70%154.25M
107.62%163.78M
4.70%112.41M
41.48%93.05M
51.01%85.36M
46.69%78.88M
125.43%107.36M
79.71%65.76M
69.06%56.53M
-60.03%53.77M
49.80%47.62M
73.76%36.59M
Total assets
20.49%1.27B
27.26%1.27B
30.18%1.21B
29.08%1.11B
24.62%1.06B
23.14%999.20M
19.33%928.13M
12.92%858.38M
18.44%846.99M
20.42%811.45M
20.87%777.77M
50.52%760.18M
54.11%715.09M
55.47%673.87M
64.53%643.46M
40.41%505.03M
37.58%464.00M
1.49%433.44M
22.19%391.09M
113.07%359.69M
Total liabilities
7.90%361.48M
18.05%401.41M
12.60%373.10M
4.73%334.93M
1.03%335.01M
-1.28%340.05M
11.77%331.33M
16.29%319.80M
21.89%331.59M
27.09%344.46M
-1.05%296.43M
6.39%275.01M
9.04%272.05M
9.76%271.03M
25.31%299.58M
10.88%258.50M
8.78%249.50M
-25.15%246.94M
6.01%239.07M
6.86%233.14M
Total equity
26.35%910.35M
32.02%870.22M
39.93%835.12M
43.54%773.08M
39.80%720.52M
41.15%659.15M
23.99%596.80M
11.01%538.58M
16.33%515.39M
15.93%466.99M
39.97%481.33M
96.80%485.17M
106.54%443.04M
115.99%402.84M
126.21%343.88M
94.81%246.53M
98.84%214.50M
91.92%186.51M
60.78%152.02M
356.43%126.55M
Cash Flow Statement
Net operating income
-18.32%27.76M
66.95%126.15M
54.23%108.73M
86.14%79.33M
9.14%33.99M
-1.44%75.56M
11.73%70.50M
14.99%42.62M
-26.83%31.14M
187.37%76.67M
14.30%63.10M
9.88%37.06M
47.51%42.56M
-28.92%26.68M
81.45%55.20M
86.67%33.73M
130.26%28.85M
273.57%37.53M
244.24%30.42M
273.97%18.07M
Net investment
-7875.02%-183.65M
-145.35%-17.63M
-742.82%-4.79M
64.29%-19.59M
138.18%2.36M
80.07%-7.19M
191.64%745.00K
-605.91%-54.86M
-245.59%-6.19M
23.09%-36.06M
97.49%-813.00K
65.38%-7.77M
95.53%-1.79M
---46.90M
-34787.10%-32.45M
-11067.66%-22.45M
59.96%-40.05M
100.00%0.00
---93.00K
-9950.00%-201.00K
Net financing
-1950.57%-7.22M
-10.00%-3.02M
-154.98%-3.00M
22.05%-2.69M
90.31%-352.00K
94.88%-2.74M
97.87%-1.18M
-916.52%-3.45M
-206.60%-3.63M
-2113.66%-53.52M
-2787.76%-55.10M
-145.20%-339.00K
146.49%3.41M
-62.42%2.66M
754.95%2.05M
15.74%750.00K
11425.00%1.38M
711.76%7.07M
-100.23%-313.00K
1067.16%648.00K

FAQs

What is the total revenue of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its total revenue reached 868.45M, with a year-on-year change of 714.73M.

What are the current assets of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its current assets were 907.01M, with a year-on-year change of 56.58.

What are the total assets of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its total assets of Harmony Biosciences Holdings Inc were 1.27B, with a year-on-year change of 27.26.

What are the total liabilities of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its total liabilities of Harmony Biosciences Holdings Inc were 401.41M, with a year-on-year change of 18.05.

What is the total equity of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its total equity of Harmony Biosciences Holdings Inc was 870.22M, with a year-on-year change of 32.02.

What is the net operating income of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its net operating income of Harmony Biosciences Holdings Inc was 208.47M, with a year-on-year change of 9.25.

What is the net investment of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its net investment of Harmony Biosciences Holdings Inc was -39.65M, with a year-on-year change of 41.25.

What is the net financing of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its net financing of Harmony Biosciences Holdings Inc was -9.05M, with a year-on-year change of 17.71.

What is the Earnings Per Share (EPS) of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.76, with a year-on-year change of 7.92.

What is the net income of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its net income was 158.69M, with a year-on-year change of 9.07.

What is the net margin of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its net profit margin was 18.27, with a year-on-year change of -10.24.

What is the gross margin of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its gross margin was 77.16, with a year-on-year change of -1.15.

What is the debt-to-asset ratio of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 12.87, with a year-on-year change of -28.26.

What is the Return on Equity (ROE) of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was 20.75, with a year-on-year change of -19.69.

What is the Return on Assets (ROA) of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was 13.98, with a year-on-year change of -13.03.

What is the operating profit of Harmony Biosciences Holdings Inc?

According to Harmony Biosciences Holdings Inc's FY2025 earnings report, its operating profit was 208.47M, with a year-on-year change of 9.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy